SCHEMBL7745894

SCHEMBL7745894

CC1(C)Sc2ccccc2NC1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.51
KMT2A Q03164 7/20 0.51
MAPT P10636 7/20 0.51
ALDH1A1 P00352 6/20 0.51
GAA P10253 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
TDP1 Q9NUW8 3/20 0.51
HPGD P15428 2/20 0.51
LMNA P02545 2/20 0.51
KDM4E B2RXH2 2/20 0.51
RUNX1 Q01196 1/20 0.51
CBFB Q13951 1/20 0.51
ALOX12 P18054 2/20 0.49
PDK2 Q15119 1/20 0.48
PDK4 Q16654 1/20 0.48
SNCA P37840 3/20 0.46
ALOX15 P16050 2/20 0.46
NOX1 Q9Y5S8 2/20 0.46
CYP1A2 P05177 1/20 0.46
BCHE P06276 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6527908 0.78 HSD17B10 (0.44) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL8024749 0.75 ALDH1A1 (0.46) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL14543844 0.75 CYP1A2 (0.42) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL10353024 0.75 MAPT (0.47) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL10511278 0.73 GAA (0.40) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL10510715 0.73 CYP1A2 (0.41) KMT2AMAPTKDM4ENOX1CYP1A2
SCHEMBL16412512 0.73 CMA1 (0.40) MEN1KMT2AALDH1A1GAAHPGD
SCHEMBL1709823 0.73 MAPT (0.54) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL10353389 0.73 ALDH1A1 (0.65) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL67627 0.72 ALDH1A1 (0.51) MEN1KMT2AMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018149754-A1 PYRIDINE COMPOUNDS BASF SE (DE) 2018-08-23 WO disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
CN-1071427-A 6-Benzoxazinyl and 6-benzothiazine base-2,3,4,5-tetrahydro pyridazine-3-ketone ORTHO PHARMA CORP (US) 1993-04-28 CN disclosed
US-5081242-A Cardiotonic and bronchodilator agents; phosphodiesterase inhibitors ORTHO PHARMACEUTICAL CORPORATION (US) 1992-01-14 US disclosed
CN-87108354-A 6-benzoxazinyl and 6-benzothiazinyl-2, 3, 4, 5-tetrahydropyridazin-3-ones 1988-09-21 CN disclosed
US-4766118-A CARDIOTONIC AGENTS, PHOSPHODIESTERASE INHIBITORS ORTHO PHARMACEUTICAL CORPORATION (US) 1988-08-23 US disclosed
US-4755509-A Heterocyclic aldose reductase inhibitors and methods of using them Carbipem (FR) 1988-07-05 US disclosed
EP-0272914-A2 6-Benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones ORTHO PHARMACEUTICAL CORPORATION (US) 1988-06-29 EP disclosed